Stock comparison

RPRXvsZTS

Royalty Pharma PLCvsZoetis Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

RPRX

Royalty Pharma PLC

$49.64

+29.34%

Pharmaceuticals$27.1BNASDAQ

ZTS

Zoetis Inc

$116.06

-2.19%

Pharmaceuticals$48.8BNYSE

60-day price, rebased to 100

RPRX +19.10% · ZTS -4.81%

Round-by-round

RPRX 2·ZTS 4

EdgeZTS

Valuation upside

-57.50% vs -36.20% to DCF fair value

EdgeZTS

Balance-sheet strength

Altman Z 2.25 vs 5.39

EdgeZTS

Fundamental quality

Piotroski 5.00 vs 6.00 (of 9)

EdgeRPRX

Growth + margins

Rule-of-40 109.80 vs 26.40

EdgeRPRX

60-day momentum

+19.10% vs -4.81% price return

EdgeZTS

Market-cap liquidity

$27.1B vs $48.8B

Verdict

Across6categories,ZTStakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onRPRXorZTS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.